In a statement Boston Scientific said it values an effective and efficient patent system that can keep pace with the rapid innovation demonstrated by the company and industry.

"Patients around the world benefit from our life-saving products, and they are worthy of a modern patent system that will protect intellectual property while advancing the development of new medical technology," the company said.

"The America Invents Act is critical to ensure the US Patent and Trademark Office has the available resources to upgrade procedures within our system, review applications in a timely manner and provide the means to strengthen protections on issued patents.

"We are confident that House and Senate negotiators can move quickly to resolve differences between the two bills and pass final legislation that will allow innovation to thrive in America."